Etodolac Tablet, Film Coated, Extended Release
Product Images NDC 68071-3731

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Etodolac (NDC 68071-3731). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Nucare Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Pdp (68071 3731 4)

Label for Etodolac 400 mg extended-release tablets by NuCare Pharmaceuticals, Inc. The label shows a package quantity of 14 tablets, details the orange, oval-shaped tablet with a "271" debossing, and includes storage instructions at controlled temperature 68-77°F. The label includes NDC 68071-3731-4 and manufacturer information for India and California.*

FDA Label Image

Etodolac Extended-release Tablets, Usp (B45f7f27 Ffc6 40a9 A0f5 B80933d641b2 01)

Chemical structure of Etodolac, depicting its molecular framework including a fused bicyclic ring system, an ethyl group, and a carboxylic acid functional group.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.